Bioinformatics Market : Future Of Blockchain Technology And It Is Creating Real Change In The Healthcare Industry

 According to the new market research report ” Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture)”, global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.

Major Growth Drivers:

Growth of the bioinformatics market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introduction of upcoming technologies such as nanopore sequencing (third generation sequencing technique) and cloud computing, the market is expected to offer significant opportunities for manufacturers of bioinformatics solutions.

Expected Revenue Growth:

[195 Pages Report] The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.

Accessories to Fuel the Growth of Bioinformatics Market :

Bioinformatics is the application of computer technology for the management and analysis of biological data. It includes collection, storage, retrieval, manipulation, and modelling of data for analysis, visualization, or prediction through algorithms and software.

However, factors such as a dearth of skilled personnel to ensure proper use of bioinformatics tools and lack of integration of a wide variety of data generated through various bioinformatics platforms are hindering market growth.

Browse in-depth TOC on “Bioinformatics Market”

189 – Tables27 – Figures195 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

By Application, the metabolomics segment is expected to grow at the highest CAGR during the forecast period

Factors such as the availability of research funding and government support are fueling market growth. However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms. Hence, the annotation of unknown metabolic signals is the main hindrance to growth of the metabolomics segment.

In 2018, The APAC market is expected to grow at the highest CAGR during the forecast period

The market in the Asia Pacific region is expected to offer significant opportunities for players to offset revenue losses incurred in mature markets. Emerging countries in this region are witnessing growth in their GDPs and a significant rise in disposable income levels. This has led to increased healthcare spending by a larger population base, healthcare infrastructure modernization, and rising penetration of cutting-edge research and clinical laboratory technologies, including bioinformatics, in Asia Pacific countries. These factors are expected to provide significant growth opportunities to bioinformatics companies operating in this region.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=39

Key Market Players

Thermo Fisher Scientific, Eurofins Scientific, Illumina, Perkinelmer, Inc., Qiagen Bioinformatics, Agilent Technologies, Dnastar, Waters Corporation, Sophia Genetics, Partek, Biomax Informatics AG, Wuxi Nextcode, Beijing Genomics Institute (BGI)

Residential air purifiers market worth $13.6 billion : Growing popularity of smart homes

 The growing awareness among consumers regarding air purification in the wake of COVID-19 is an opportunity for air purifier retailers to scale up their sales. Some companies are increasing the production of air quality systems with the addition of different technologies such as High-Efficiency Particulate Air (NASDAQ:HEPA) filters, photocatalytic purifiers, activated carbon purifiers, and ionic filters.

[131 Pages Report] The residential air purifiers market is projected to reach USD 13.6 billion by 2025 from USD 9.2 billion in 2020, at a CAGR of 8.2% during the forecast period.

Market Dynamics

• Growing popularity of smart homes
• Increasing urbanization and indoor air pollution
• Supportive government regulations for effective air pollution monitoring and control
• Increasing public awareness pertaining to the healthcare implications of air pollution

COVID-19 Impact on Global Residential Air Purifiers Market

The COVID-19 outbreak has generated major remunerative opportunities for air purifier manufacturers, with high-performance units, comprising HEPA and activated carbon technologies, being highly popular, to minimize the spread of the virus for enclosed spaces. Premium, high-performance air purifiers are capable of filtering out particles up to 1 micron, and the size of the COVID-19 virus is estimated to be around 1.2 microns. Consequently, manufacturers have displayed confidence in being able to provide a solution for indoor environments, during the outbreak, which will sustain demand for the near future.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40172748

Based on technology, the residential air purifiers market is segmented into HEPA filters (high-efficiency particulate arrestence or high-efficiency particulate air) and other technologies. The other technologies segment comprises electrostatic precipitators, activated carbon, UV filters, and ionic filters. The HEPA segment accounted for the larger market share in 2019. The growing concern for environmental sustainability, increasing public awareness pertaining to the healthcare implications of air pollution, and the growing popularity of smart homes/ambient-assisted living has resulted in the increased adoption of the HEPA technology in the residential air purifiers market.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. RoW5. Latin America6. Middle East & Africa

Asia Pacific is the largest regional market for residential air purifiers. The fast adoption of advanced indoor air quality monitoring technologies, ongoing technological advancements in the field of particulate sensors, rising public-private funding and investments, and the presence of supportive government regulations are key factor driving the residential air purifiers market in Asia Pacific.

Request for sample pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=40172748

Some key players mentioned in the research report are:

The top market players in the global residential air purifiers market include Daikin Industries, Ltd. (Japan), Sharp Corporation (Japan), Honeywell International Inc. (US), Samsung Electronics Co., Ltd. (South Korea), LG Electronics Inc. (South Korea), Koninklijke Philips N.V. (Netherlands), Dyson (NASDAQ:UK), Unilever Group (UK), Panasonic Corporation (Japan), Whirlpool Corporation (US), AllerAir Industries Inc. (US), IQAir (Switzerland), WINIX Co., Ltd. (South Korea), Xiaomi Corporation (China), Camfil AB (Sweden), Alen Corporation (US), Airgle Corporation (US), Hunter Pure Air (US), Kent RO Systems Ltd. (India), and HSIL Limited (India).

Medical Device Reprocessing Market – By 2022, Industry Is Expecting To Grow At CAGR Of 16.3%

 According to the new market research report “Medical Device Reprocessing Market by Product (Reprocessed Device (Catheter, Endoscope, Laparoscopic Instruments, Biopsy, Pulse Oximeter), Service), Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia)”, published by MarketsandMarkets™, medical device reprocessing market is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016.

Major Growth Drivers:

The key factors driving the growth of this market include the low prices of reprocessed devices as compared to new ones and the pressure to reduce the volume of medical waste generated. The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat multiple patients.

Expected Revenue Growth:

[145 Pages Report] The global medical device reprocessing market is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=583

Objectives of the Study :

1. To define, describe, and forecast the global market with respect to product & service, type of device, application, and region

2. To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

3. To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

Browse in-depth TOC on ” Medical Device Reprocessing Market “

75 – tables24 – figures145 – pages

The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent.

The reprocessing practices are regulated by various regional regulatory authorities. The changing regulatory scenario favoring medical device reprocessing in a number of countries, such as France and Japan, will open up new areas of opportunity for market players.

Request for sample pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=583

In 2016, Stryker Corporation (U.S.) and Johnson & Johnson (U.S.) dominated the global medical device reprocessing market. Some of the other players competing in this market are Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.)

Pharmacy Automation Market Is Expanding at 8.2% With Increasing Demand for Medical device Industry

 The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost. On the other hand, reluctance among the healthcare organizations to adopt pharmacy automation systems is expected to restrain the overall market growth to a certain extent during the forecast period. 

[218 Pages Report] MarketsandMarkets forecasts the pharmacy automation market is estimated to grow from USD 3.63 billion in 2017 to USD 5.38 Billion by 2022, at a Compound Annual Growth Rate (OTC:CAGR) of 8.2% during the forecast period.

Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

• Growing Need to Minimize Medication Errors
• Decentralization of Pharmacies
• Rising Geriatric Population
• Rising Labor Cost

Based on product, the pharmacy automation market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy automation systems. Automated medication dispensing systems accounted for the largest share of the pharmacy automation market in 2016. 

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71522890 

On the basis of end users the market is classified into inpatient pharmacies, outpatient pharmacies, pharmacy benefit management organization and mail order pharmacies, and retail pharmacies. Retail pharmacies is the fastest growing end user segment in the pharmacy automation market during the forecast period.  

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East and Africa

North America is expected to hold the largest market size in the pharmacy automation market during the forecast period, followed by the European region. The large share of the North American pharmacy automation market can largely be attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population.  

Some key players mentioned in the research report are:

Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst Systems, LLC (U.S.).

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=71522890

Anatomic Pathology Market USD 46.8 billion by 2025 – Increasing Investment In Histopathology

 The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.

[306 Pages Report] The global anatomic pathology market size is estimated to grow from USD 33.3 billion in 2020 to USD 46.8 billion by 2025, at a CAGR of 7.1%.

Market Dynamics

• High incidence of cancer and other target diseases
• Recommendations for cancer screening
• Availability of reimbursement
• Growing focus on personalized medicine

COVID-19 Impact on Anatomic Pathology Market

Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145 

By product & service, the anatomic pathology market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

The geographical regions mapped in the report are:

Based on the region, the global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the anatomic pathology market in North America.

Request for sample pages @   https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html 

Some key players mentioned in the research report are:

Prominent players in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), PHP Holdings Corporation (Japan), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (OTCPK:ITALY), and BioGenex Laboratories (US).

3D Printing Medical Devices Market worth USD 5.1 billion : Growing Applications of 3D Printing

 What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Expected Revenue Growth:

[497 Pages Report] The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period.

Major Growth Boosters:

Increasing public-private funding for 3D printing activities, high incidence of dental and orthopedic diseases, easy development of customized medical products using 3D printing, growing applications of 3D printing in the healthcare industry, availability of advanced 3D printing materials for dental and medical applications, and the increasing demand for 3D-printed products in the cosmetics and pharmaceutical industries, are the key factors supporting the growth of the market.

COVID-19 Impact on the global 3D Printing Medical Devices market

As a result of the pandemic, during March 2020 and throughout the second quarter of 2020, access to customers to sell and implement the 3D Printing Medical Devices diminished as hospitals became primarily focused on the COVID-19 pandemic. The pandemic has led to a significant increase in the demand for ventilators. The closure of manufacturing facilities due to lockdowns and disrupted supply chains slightly impacted the growth of the 3D Printing Medical Devices market at the regional level in 2020.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911 

Driver: Increasing public-private funding for 3D printing activities

In recent years, there has been a significant increase in public-private funding to support various initiatives in the 3D printing industry. Such research and funding activities are expected to boost the development of 3D printing products and technologies, thereby driving the growth of the 3D printing medical devices market.

Regional Growth Analysis:

The report covers the 3D Printing Medical Devices market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America, and MEA. North America commanded the largest share of the 3D Printing Medical Devices market in 2020. Market growth is mainly attributed to the strong base of healthcare facilities, especially hospitals and diagnostic imaging centers, and the growing installation base for 3D printer in healthcare facilities.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=90799911 

Recent Developments

• In April 2021, 3D Systems (US) introduced launched titanium- and nylon-made patient-specific VSP Hybrid Guides for maxillofacial procedures
• In March 2021, Stratasys Ltd. (US) Introduced the J5 DentaJet 3D Printer PolyJet printer for dental laboratories
• In February 2021, Desktop Metal, Inc. (US) acquired EnvisionTEC (Germany). This acquisition will strengthen the company’s existing client base of 3D Printing Medical Devices

Women’s Health Diagnostics Market worth USD 36.6 billionUSD 36.6 billion : Increasing adoption of point-of-care and rapid diagnostic tests

 The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.

COVID-19 Impact on Global Women’s Health Diagnostics Market :

Since the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.

Expected Revenue Growth:

The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Diagnostic tests such as POC tests are commonly used to detect HIV among patients. A rapid POC HIV test enables physicians to provide results and the HIV status of patients during the same visit. It does not require pre-test and post-test counseling of patients, as is common during traditional laboratory analysis.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901 

Recent Developments

• In 2021, F. Hoffmann-La Roche Ltd. Launched the uPath HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
• In 2021, Hologic, Inc. acquired Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, to strengthen its presence in the women’s health diagnostics market.
• In 2020, Hologic, Inc. launched the 3DQuorum Imaging Technology in Europe.
• In 2019, Carestream Health, Inc. opened a new global business operations center in Mumbai, India, expanding its market presence.

Frequently Asked Questions (FAQs) :

• Which are the top industry players in the global women’s health diagnostics market?
• Which global women’s health diagnostics appications have been included in this report?
• Which geographical region is dominating in the global women’s health diagnostics market?
• Which is the leading global women’s health diagnostics end user segment?

Request for sample pages :   https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901 

Major Growth Boosters:

The market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

Regional Growth Analysis:

In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing prevalence of cancer among women, the growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and the increasing demand for fertility testing monitors.

Laboratory Filtration Market Worth USD 4.1 billion – Current Status, Statistics, Growth Dynamics And Future Trends

 Growth in this market is driven majorly by the rising R&D spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals. However, the high cost of systems is expected to restrain the growth of the lab filtration market to a certain extent during the forecast period.

[221 Pages Report] The global laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period.

Market Dynamics

• Rising R&D Spending in the Pharmaceutical & Biopharmaceutical Industry
• Growing Demand for Membrane Filtration Technology
• Increasing Purity Requirements in End-User Segments
• Focus on Developing Large-Molecule Biopharmaceuticals

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure@  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082 

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories). The filtration media segment accounted for the largest market share in 2018.

The geographical regions mapped in the report are:

The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.

Some key players mentioned in the research report are:

The prominent players in the global lab filtration market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US) 

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082 

Laboratory Freezers Market : Analysis of Worldwide Industry Trends and Opportunities

 The global laboratory freezers market is projected to reach USD 3.76 Billion by 2021, at a CAGR of 4.6% from 2016 to 2021.

This research study involved extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.

Market Dynamics

• Increasing Demand for Blood and Blood Components for Transfusion and Production of Biopharmaceuticals
• Growing Number of Organ Transplant Procedures
• Rising Government Support for Research Activities and Clinical Trials
• Technological Advancements in Laboratory Freezers and Refrigerators

The laboratory freezers market studied in this report is segmented by product type, end user, and region. Based on end user, the market is segmented into hospitals, medical laboratories, pharmacies, blood banks, academic & research institutes, and pharmaceutical and biotechnology companies. In 2015, the blood banks segment accounted for the largest share of the market, owing to the increasing demand for whole blood and blood components as a result of the rising prevalence of blood disorders such as sickle cell anemia, blood cancer, and hemophilia.

Download PDF Brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196600540 

Based on end user, the laboratory freezers market is segmented into hospitals, medical laboratories, pharmacies, academic & research institutes, blood banks, and pharmaceutical & biotechnology companies. The blood banks segment accounted for the largest share of the market in 2015. The large share of this segment can be attributed to the rising demand for whole blood and blood components, owing to the increasing prevalence of blood disorders such as sickle cell anemia, blood cancer, and hemophilia.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East and Africa (MEA)

Geographically, North America dominated the global laboratory freezers market in 2015. The large share of this regional segment can be attributed to the presence of developed healthcare systems in the U.S. & Canada and growing R&D spending on pharmaceuticals & biotechnology in this region. However, the Asia-Pacific region is expected to register the highest growth in the coming years, due to a growth in research activities & pharmaceutical manufacturing and increasing investments by leading players and respective government agencies in emerging APAC countries.

Some key players mentioned in the research report are:

The key players in this market are Thermo Fisher Scientific Inc. (U.S.), Haier Biomedical (CHINA), Eppendorf AG (Germany), Helmer Scientific (U.S.), VWR Corporation (U.S.), ARCTIKO A/S (Europe), Biomedical Solutions Inc. (U.S.), EVERmed S.R.L. (OTCPK:ITALY), Philipp Kirsch GmbH (Germany), and Panasonic Healthcare Co., Ltd. (Japan).

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=196600540 

Intraoperative Radiation Therapy Market Worth USD 66 Million : Improving Reimbursement Scenario

 [159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

Market Dynamics

• Growing global prevalence of cancer
• Improving reimbursement scenario
• Procedural advantages over EBRT
• Technological advancements

COVID-19 Impact on the global Intraoperative radiation therapy market

The intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic. Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market. The pandemic also impacted the availability of healthcare resources. Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.  

Download PDF Brochure

@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083

The IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue. This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy). The increasing prevalence of breast cancer is, therefore, a key factor driving the market growth. The growing prevalence of cancer will increase the adoption of IORT procedures.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

North America, comprising the US and Canada, accounted major share of the intraoperative radiation therapy market in 2019. The major factors driving market growth in this region are the easy availability and high adoption of IORT for cancer treatment, the rising incidence of cancer, and significant per capita annual healthcare expenditure in the US and Canada.  

Some key players mentioned in the research report are:

The major players in the Intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (OTCPK:ITALY), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083

Tensiometer Market To Reach USD 151 Million By 2024 – Growing Demand For Cosmetics Industry

 The global market for tensiometer global market for tensiometer global market for tensiometer is primarily driven by the need to improve product quality and manufacturing processes, increasing pharmaceutical and biopharmaceutical R&D expenditure, and technological advancements. However, the reluctance to switch from conventional methods and a dearth of skilled personnel will challenge market growth.

[131 Pages Report] The global tensiometer market is expected to reach USD 151 million by 2024 from an estimated value of USD 103 million in 2019, growing at a CAGR of 7.9% during the forecast period.

This study on the global tensiometer market involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices

2. Pressure to Reduce Volume of Regulated Medical Waste

On the basis of product, the tensiometer market is segmented into optical tensiometers, force tensiometers, volumetric tensiometers, bubble pressure tensiometers, and accessories. The optical tensiometers segment accounted for the largest market share in 2018. The large share of this segment is mainly attributed to the large adoption of optical tensiometers in the chemical, oil & gas, energy, pharmaceutical, and material & coating industries in the R&D and quality control of products.

Download PDF Brochure@  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10015314 

The geographical regions mapped in the report are:

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, Asia Pacific accounted for the largest share of the tensiometer market. The factors such as chemical production growth in China, growth in Indian oil & gas industry, increasing demand for primary energy in India, and growth in medical device & pharmaceutical market in Asia are driving the growth of the tensiometer industry in this region.

Some key players mentioned in the research report are:

The key players in the global tensiometer market are KRÜSS GmbH (Germany), DataPhysics Instruments GmbH (Germany), Biolin Scientific AB (Sweden), Kyowa Interface Science Co. Ltd. (Japan), LAUDA Scientific GmbH (Germany), TECLIS Scientific (France), Apex Instruments Co. Pvt. Ltd. (India), Pro-Pack Materials (Singapore), USA KINO Industry Co. Ltd. (US), and Kibron Inc. Oy (Finland).

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=10015314 

Dental Impression Systems Market : Analysis of Worldwide Industry Trends and Opportunities

 According to the new market research report “ Dental Impression Systems Market by Product (Impression Material, Intraoral Scanners, Trays), Application (Restorative and Prosthodontics Dentistry, Orthodontics), End User (Hospitals, Dental Laboratories, Forensic Laboratories) – Global Forecast to 2025″, published by MarketsandMarkets™, global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period.

Major Growth Drivers:

The growth in the dental impression systems market is mainly driven by factors such as the rising incidence of dental diseases, increasing demand for cosmetic dentistry. In addition, growing dental tourism in emerging markets and rising adoption of digital dentistry are expected to drive demand growth in the dental impression systems market during the forecast period.

Expected Revenue Growth:

[171 Pages Report] The global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period.

Covid-19 Impact on the Dental impression systems Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities on a daily basis. As of December 2020, 63.8 million cases of COVID-19 have been reported across Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in approximately 1.5 million deaths. With the COVID-19 pandemic, most countries, including the whole of Europe, the US, India, and Australia, among others, are following complete nationwide lockdowns. This also affected the supply chain for dental impression materials and scanners.

By product, segment, the intraoral scanners segment is expected to grow at the highest growth rate during the forecast period

Among the product, segment, the intraoral scanners segment is expected to grow at the highest CAGR during the forecast period. The intraoral scanners segment is estimated to grow at the highest CAGR during the forecast period as these scanners increase the accuracy of dental impressions and reduce the time involved in procedures.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256609208 

Asia-Pacific is the fastest growing market for dental impression systems market during the forecast period

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high growth in this regional market can be attributed to the rising patient volume, growing medical tourism, and increasing disposable incomes.

Key Market Players

The major players in the global dental impression systems market are 3M (US), Henry Schein (US), Dentsply Sirona (US), Mitsui Chemicals (Japan), and Envista (US). Other prominent players in this market include Parkell, Inc. (US), Kettenbach GmbH & Co. KG (Germany), Zest Dental Solutions (US), Keystone Industries (US), Ultradent Products, Inc. (US), Septodont Holding (US), GC Corporation (US), DETAX (Germany), Kerr Corporation (US), Ivoclar Vivadent (US), Kuraray Co. Ltd. (Japan), BEGO (Germany), Premier Dental Products Company (US), and DMG America (US).

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=256609208 

Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer

 Major Growth Drivers:

Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays. On the other hand, Uncertain reimbursement scenario in different regions is expected to restrain the growth of this market during the forecast period.

Expected Revenue Growth:

[116 Pages Report] The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period.

Recent Developments: 

1. In May 2018, Adaptive Biotechnologies (US) collaborated with Sanofi, SA. (US), to utilize Adaptive’s clonoSEQ Assay to measure MRD status in response to isatuximab2. In July 2018, Abbott Laboratories (US) received FDA approval for its Abbott RealTime IDH1 kit3. In May 2018, Invivoscribe, Inc. (US) partnered with the American University of Beirut Medical Center (AUBMC) (Lebanon) to create a new center of excellence facility in the Middle East

Browse in-depth TOC on “Hemato Oncology Testing Market“

77 – Tables29 – Figures116 – Pages

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=262472877 

“The services segment accounted for the largest share of the hemato oncology testing in 2018”

Based on product & services, the hemato oncology testing is segmented into services and assay kits. In 2018, the services segment accounted for the largest share of the hemato oncology testing. This is mainly due to the increasing prevalence & incidence of leukemia, non-Hodgkin lymphoma, and myeloma cancers. Apart from this, rising awareness regarding advanced treatment therapies such as personalized medicine is also driving the growth of this segment.

“Asia Pacific to register the highest growth rate during the forecast period (2019–2024)”

Based on region, the hemato oncology testing is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC market is driven mainly by the large patient population, and increasing focus of major players on expanding in this region will drive market growth.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=262472877 

Key Market Players

Prominent players in the hemato oncology testing market include F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Germany), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), MolecularMD (Ireland), Invivoscribe, Inc. (US), Asuragen, Inc. (US), Adaptive Biotechnologies (US), ArcherDx, Inc. (US), and ARUP Laboratories Inc. (US).

Genotyping Assay Market Worth USD 31.9 Billion : Increasing Application Areas Of Genotyping

 MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (OTC:CAGR) of 22.0% during the forecast period.

The sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices2. Pressure to Reduce Volume of Regulated Medical Waste

The report analyzes the market by product & service, type of medical device, application, and region. On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.

Download PDF Brochure@   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595 

The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period. The increasing demand for pharmacogenomics in the drug discovery and development process and recommendations from the FDA to include genotyping and pharmacogenomics studies in the course of drug discovery have contributed to the growth of this market segment.

The geographical regions mapped in the report are:

North America is expected to hold the largest market size in the global genotyping market during the forecast period, followed by the European region. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

Some key players mentioned in the research report are:

Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Request for sample pages
@   https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595 

Autoinjectors Market Worth $ 104.9 Billion : Rising Incidence Of Anaphylaxis

 Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market.

[180 Pages Report] The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025.

Market Dynamics

• Growing prevalence of targeted therapies
• Rising incidence of anaphylaxis
• Increasing number of regulatory approvals
• Availability of generic versions of autoinjectors
• Favorable reimbursements and government support
• Ease of use increasing the preference for self-administration

COVID-19 Impact on The Autoinjectors Market

The COVID-19 pandemic has resulted in a global healthcare crisis, causing a shift in healthcare delivery in most regions. Most non-essential procedures and in-hospital therapies were deferred in the first half of 2020 to prevent the spread of the infection and ease the toll on healthcare infrastructure. According to researchers at Indiana University, healthcare visits decreased by around 40% in the first six weeks of the pandemic in the US, from early March to mid-April. After restrictions were eased, there has been an overall decline in patients delaying seeking care and treatment in healthcare settings.

In summary, the COVID-19 pandemic has been accelerating the trend of self-injection, empowering patients to have more involvement and control over their treatment. Newer technologies in the autoinjectors market have encouraged this trend, as they allow better management of injection speed, injection site pain, and treatment anxiety.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724 

Opportunity: Need to limit patient visits and physical contact

The current COVID-19 pandemic has resulted in the implementation of a fresh set of protocols that aim to reduce patient visits to hospitals and clinics in non-emergency conditions to prevent both the transmission of the virus as much as make sure healthcare institutions are not overwhelmed. In this situation, the preference for home-use autoinjectors has risen among patients suffering from chronic illnesses and allergies. This also protects vulnerable high-risk populations from exposure to the virus during hospital visits.

Autoinjectors are being developed to support increased viscosity and concentrations of drugs to reduce administration frequency, thus increasing adherence to recommended drug protocols. These factors present an opportunity for the growth of the autoinjectors market in the current COVID-19 scenario.

The geographical regions mapped in the report are:

Geographically, the autoinjectors market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the Asia Pacific market is majorly driven by the large diabetes population and increasing healthcare expenditure which has drawn a number of major autoinjector device manufacturers to this region. These companies are increasing their presence in the Asia Pacific market through several approaches, such as establishing sales offices and partnering with local pharmaceutical companies

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724 

Patient Access Solutions Market Worth USD 2.4 Billion : Growing Importance Of Denials Management

 According to the new market research report ”Patient Access Solutions Market by product & service (Training services, Eligibility Verification, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End-User (Providers, HCIT Outsourcing Companies) – Global Forecast to 2025“,published by MarketsandMarkets™, global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.

Major Growth Drivers:

Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market. However, high deployment costs are expected to restrain the growth of this market to a certain extent.

Expected Revenue Growth:

[207 Pages Report] The global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.

Browse in-depth TOC on “Patient Access Solutions Market”

103 – Tables58 – Figures207 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=280473

Healthcare Providers was the largest end-user for the Patient access solutions market in 2019

Based on end-users, the patient access solutions market is segmented into healthcare providers, HCIT outsourcing companies, and other end users. In 2019, the healthcare providers segment accounted for the largest share of the global patient access solutions market. Growing HCIT adoption, significant growth in healthcare spending, increasing healthcare costs, and declining reimbursement rates are the major factors supporting the adoption of patient access solutions among healthcare providers.

APAC market to witness the highest growth during the forecast period

The Asia Pacific market is comparatively new to patient access solutions; however, this region is expected to register the highest growth in the coming years. Countries such as Japan, Australia, New Zealand, South Korea, and Singapore are expected to provide significant growth opportunities for vendors of patient access solutions.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=280473

Key Market Players

The market is dominated by a few globally established players such as McKesson (US), Cerner (US), Optum (US), 3M (US) and Experian Plc (Ireland)

Esoteric Testing Market : Future Of Mass Spectrometry, It Is Creating Real Change In The Medical Device Industry

 According to the new market research report ”Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) – Global Forecast to 2023“, published by MarketsandMarkets™, MarketsandMarkets forecasts the global esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%.

Major Growth Drivers:

The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The objective of the report is to define, describe, and forecast the esoteric testing market size based on type, technology, laboratory type, and regions.

Expected Revenue Growth:

[223 Pages Report] MarketsandMarkets forecasts the global esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%.

Accessories to Fuel the Growth of Esoteric Testing Market :

The MnM repository is referred to for high-level insights into the esoteric testing market. Each of the technologies, types, and end users involved in the esoteric testing services were analyzed through secondary research and validated with primary interviews. MnM also identified the key service providers in this market for the assigned countries and conducted interviews with the key industry experts to arrive at the market splits and shares. MnM triangulated all of this data to estimate the market size and forecast the growth of this market.

Browse in-depth TOC on “Esoteric Testing Market“

110 – Tables

37 – Figures223 – Pages

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708 North America to account for the largest market size during the forecast period.

North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, development in healthcare infrastructure, and significant rise in the disposable income in the region.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708 

LabCorp (US), Quest Diagnostics (US), OPKO Health (US), Miraca Holdings (US), ARUP Laboratories (US), Myriad Genetics (US), Genomic Health (US), American Medical Laboratories (US), Foundation Medicines (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (UK), Fulgent Genetics (US), Spectra Laboratories (US), Nordic Lifesciences (US), InVitae (US), Unilabs (Switzerland), and SYNLAB (Germany).